Literature DB >> 28974557

Utility of DXA screening for diagnosis of osteoporosis in US veterans aged 70 years and older.

Joanna Khatib1, Kim Stote2, Aidar R Gosmanov1,3.   

Abstract

Dual energy X-ray absorptiometry (DXA) is recommended for osteoporosis screening in men aged 70 years and older but supportive data is limited. The aim of this study was to determine the efficacy of DXA for the diagnosis of increased fragility in this group of subjects. We retrospectively identified men aged 70 years and older without prior history of fracture and/or conditions predisposing to low bone mineral density (BMD) who attended the VA endocrinology clinic and performed DXA for osteoporosis screening. We analyzed the relationship between BMD and demographic, anthropometric data and biochemical parameters using linear regression models. Out of 55 subjects identified, 13 (24%) men had normal BMD, 30 (54%) had osteopenia and 12 (22%) had a diagnosis of osteoporosis based on the femoral neck (FN) T-score. Lumbar spine T-scores were normal in all three groups. Weight and body mass index (BMI) were significantly higher in the normal BMD group compared with the osteopenia and osteoporosis groups (p<0.001). After adjustments for age, weight, BMI, vitamin D concentrations, and diabetes status, differences in the FN BMD among the groups remained significant (p<0.001). Based on the Fracture Risk Assessment Tool (FRAX) score calculations in 43 non-osteoporotic patients, 15 patients with osteopenia had a 10-year hip fracture probability ≥3%. Screening with DXA in male US veterans aged 70 years and older without known osteoporosis risk factors revealed that up to 50% of men may qualify for diagnostic workup to determine the etiology of low BMD and/or to meet criteria to initiate pharmacological therapy to reduce future fracture risk. © American Federation for Medical Research (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  Osteoporosis; Risk

Mesh:

Year:  2017        PMID: 28974557     DOI: 10.1136/jim-2017-000557

Source DB:  PubMed          Journal:  J Investig Med        ISSN: 1081-5589            Impact factor:   2.895


  4 in total

1.  Association of bone-related biomarkers with femoral neck bone strength.

Authors:  Ning Xia; Yun Cai; Wei Wang; Chen Bao; Yunming Li; Qingyun Xie; Wei Xu; Da Liu
Journal:  BMC Musculoskelet Disord       Date:  2022-05-21       Impact factor: 2.562

Review 2.  Emerging roles of circular RNAs in osteoporosis.

Authors:  Weichun Chen; Baozhong Zhang; Xiao Chang
Journal:  J Cell Mol Med       Date:  2021-09-06       Impact factor: 5.310

3.  Meta-Analysis of Effects of Nutritional Intervention Combined with Calcium Carbonate D3 Tablets on Bone Mineral Density, Bone Metabolism, and Curative Effect in Patients with Osteoporosis.

Authors:  Hua Ni; Shuchen Zhang; Xiaowen Niu; Sha Dai
Journal:  Contrast Media Mol Imaging       Date:  2022-06-24       Impact factor: 3.009

4.  Circular RNA_0062582 promotes osteogenic differentiation of human bone marrow mesenchymal stem cells via regulation of microRNA-145/CBFB axis.

Authors:  Feng Li; Hao Wu; Guoyou Zou; Dingwei Cang; Yixin Shen
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.